The Ricci Prize


The Stephen and Geraldine Ricci Interdisciplinary Prize is awarded annually within the $100k New Ventures Competition. The purpose of the prize is to promote the advancement of research at Tufts through projects that assist in translation of research discoveries from the laboratory to applications that benefit society. To win the prize, students must demonstrate the commercial potential of the technology within their online application. Winners are selected that best demonstrate interdisciplinary engineering design and entrepreneurial spirit in their venture.


The winning team will receive a cash prize of $15,000, split evenly among the student team members.

UCHU Biosensors and Tarsier Ricci Prize Winners
Spotlight Parking Ricci Prize 2015 Winners
Sophia Atik Ricci Prize Winner

Team Requirements

  • The team may consist of a minimum of two to a maximum of five members.
  • At least two of the team members must be matriculated, degree-earning undergraduate or graduate students, or recent alumni (graduated within the last two years) from the Tufts University School of Engineering.
  • Team members must represent at least two Tufts University School of Engineering departments, or two different Tufts schools.
  • Non-Tufts team members are permitted, but Tufts engineering students must constitute at least half of the team.
  • The team must have a faculty advisor in Tufts University School of Engineering.
  • Demonstrates interdisciplinary engineering design and entrepreneurial spirit.
  • Demonstrates commercial potential.>

Intellectual Property

Intellectual property will be managed according to the practices and policies of Tufts Office for Technology Licensing and Industry Collaboration,

Past Winners

2021 Winners


Cerobex is developing a novel lipid nanoparticle-based drug delivery platform. Our platform is the only technology, demonstrated in animal models, to safely and effectively deliver a wide variety of compounds across the blood-brain barrier, improving existing treatments, and enabling the treatment of currently untreatable neurological diseases.

Team Members: Lia Aftandilian (EG21, EG22), Kayla Fisher (EG21, EG22), Darian Matini (EG21), and Benjamin Webb (EG21, EG22)

2020 Winners


How do we monitor bladder cancer? Current clinical methods are painful, provide low clinical accuracy, and have hardly evolved in decades. Cellens, a Tufts University spinout startup, develops a high-performing, efficient cell surface scanning technology platform for bladder cancer diagnostics. The core technology leverages the power of atomic force microscopy imaging and machine learning modeling. There are two main applications for our technology. First, we are developing a clinical non-invasive urine-based cancer monitoring test for bladder cancer survivors. Second, we provide a laboratory-developed test (LDT) for biotech and pharmaceutical companies that want to use this test for R&D purposes.

Team Members: Srushti Acharekar (EG20), Nathaniel Niemiec (A20), Jean Phuong Pham (EG21), Jonas Pirkl (EG20), Igor Sokolov (School of Engineering Faculty), Fiona Xueying Wang (EG20)